Lessons learnt inform our approach to new antivascular endothelial growth factor treatments for neovascular age-related macular degeneration (vol 41, pg 723, 2013)

被引：0
|
作者：
Wickremasinghe, S.
Abedi, F.
Sandhu, S. S.
Guymer, R.
机构：
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2013年 / 41卷 / 09期
关键词：
D O I：
10.1111/ceo.12263
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：902 / 902
页数：1
相关论文
共 50 条
  • [31] Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials
    Maguire, Maureen G.
    Martin, Daniel F.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Daniel, Ebenezer
    Grunwald, Juan E.
    Toth, Cynthia A.
    Ferris, Frederick L., III
    Fine, Stuart L.
    OPHTHALMOLOGY, 2016, 123 (08) : 1751 - 1761
  • [32] Switching Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
    Schachat, Andrew P.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (01) : 1 - 2
  • [33] Anti vascular endothelial growth factor sequential therapy for neovascular age-related macular degeneration: is this the new deal?
    Neri, Piergiorgio
    Mariotti, Cesare
    Arapi, Ilir
    Bambini, Elisa
    Giovannini, Alfonso
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 395 - 400
  • [34] Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration
    Hussain, Rehan M.
    Ciulla, Thomas A.
    EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (03) : 235 - 246
  • [35] Does the Inhibition of Vacular Endothelial Growth Factor in Neovascular Age-Related Macular Degeneration Result in Macular Atrophy?
    Chakravarthy, Usha
    OPHTHALMOLOGY, 2020, 127 (04) : 533 - 534
  • [36] Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with antivascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761)
    Gillies, Mark C.
    Daien, Vincent
    Nguyen, Vuong
    Barthelmes, Daniel
    OPHTHALMOLOGY, 2017, 124 (03) : E31 - E32
  • [37] Can genetic factors predict response to antivascular endothelial growth factor therapy in age-related macular degeneration?
    Micieli, Jonathan A.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2011, 46 (06): : 549 - 551
  • [38] Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
    Hussain, Rehan M.
    Shaukat, Bilal A.
    Ciulla, Lauren M.
    Berrocal, Audina M.
    Sridhar, Jayanth
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2653 - 2665
  • [39] Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
    Hata, Masayuki
    Yamashiro, Kenji
    Ooto, Sotaro
    Oishi, Akio
    Tamura, Hiroshi
    Miyata, Manabu
    Ueda-Arakawa, Naoko
    Takahashi, Ayako
    Tsujikawa, Akitaka
    Yoshimura, Nagahisa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (01) : 292 - 298
  • [40] Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
    Chen, Yu-Yen
    Chou, Pesus
    Huang, Yu-Fang
    Chien, Hung-Jen
    Wu, Yu-Chieh
    Lee, Chia-Chi
    Huang, Li-Ying
    Chen, Hsin-Hua
    BMC OPHTHALMOLOGY, 2019, 19 (01)
12345